| Literature DB >> 32961083 |
Yuwei Ling1, Jing Zhao1, Ye Zhao1, Kaifu Li1, Yajun Wang1, Hua Kang1.
Abstract
OBJECTIVE: To investigate whether intraoperative neuromonitoring (IONM) has a significant advantage in reducing the incidence of recurrent laryngeal nerve (RLN) injury.Entities:
Keywords: Intraoperative neuromonitoring; lymph node dissection; nerve injury; parathyroid surgery; recurrent laryngeal nerve; thyroid surgery
Mesh:
Year: 2020 PMID: 32961083 PMCID: PMC7513400 DOI: 10.1177/0300060520952646
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Clinical characteristics in IONM group and VA group.
| Variable | IONM (n = 701) | VA (n = 332) | |
|---|---|---|---|
| Age, years | 52 (40, 59) | 52 (43.25, 59) | 0.200 |
| Sex | 0.230 | ||
| Male | 182 (26.0) | 98 (29.5) | |
| Female | 519 (74.0) | 234 (70.5) | |
| Thyroid disease | <0.001 | ||
| Benign | 314 (44.79) | 241 (72.59) | |
| Malignant | 387 (55.21) | 91 (27.41) | |
| Reoperation | 34 (4.85) | 18 (5.42) | 0.695 |
| Graves’ disease | 6 (0.86) | 3 (0.90) | 0.939 |
| Retrosternal goiter | 19 (2.71) | 6 (1.81) | 0.367 |
Data are presented as median (lower quartile, upper quartile) or n (%).
IONM, intraoperative neuromonitoring; VA, visualization alone.
Incidence of RLN palsy in IONM group and VA group.
| Variable | Patients (n = 1033) | Nerves at risk (n = 1696) | ||||
|---|---|---|---|---|---|---|
| IONM (n = 701) | VA (n = 332) | IONM (n = 1104) | VA (n = 592) | |||
| RLN palsy | ||||||
| Overall | 25 (3.57) | 8 (2.41) | 0.324 | 26 (2.36) | 8 (1.35) | 0.160 |
| Transient | 23 (3.28) | 7 (2.11) | 0.295 | 24 (2.17) | 7 (1.18) | 0.146 |
| Permanent | 2 (0.29) | 1 (0.30) | 0.965 | 2 (0.18) | 1 (0.17) | 0.954 |
Data are presented as n (%).
RLN recurrent laryngeal nerve; IONM, intraoperative neuromonitoring; VA, visualization alone
Incidence of RLN palsy in different surgical procedures and risk classification.
| Overall RLN palsy | Transient RLN palsy | Permanent RLN palsy | |||||||
|---|---|---|---|---|---|---|---|---|---|
| IONM | VA | IONM | VA | IONM | VA | ||||
| Thyroidectomy | 20/661 (3.02) | 3/124 (2.42) | 0.713 | 19/661 (2.87) | 3/124 (2.42) | 0.778 | 1/661 (0.15) | 0/124 (0.00) | 0.665 |
| Subtotal thyroidectomy | 6/416 (1.44) | 5/466 (1.07) | 0.622 | 5/416 (1.20) | 5/466 (1.07) | 0.857 | 1/416 (0.24) | 0/466 (0.00) | 0.290 |
| Central LN dissection | 16/503 (3.18) | 3/94 (3.19) | 0.996 | 16/503 (3.18) | 3/94 (3.19) | 0.996 | 0/503 (0.00) | 0/94 (0.00) | – |
| Lateral LN dissection | 0/75 (0.00) | 2/17 (11.76) |
| 0/75 (0.00) | 2/17 (11.76) |
| 0/75 (0.00) | 0/17 (0.00) | – |
| Reoperation | 1/51 (1.96) | 1/34 (2.94) | 0.770 | 1/51 (1.96) | 1/34 (2.94) | 0.770 | 0/51 (0.00) | 0/34 (0.00) | – |
| High-risk group | 18/593 (3.03) | 4/150 (2.67) | 0.812 | 18/593 (3.03) | 3/150 (2.00) | 0.494 | 0/593 (0.00) | 1/150 (0.67) |
|
| Low-risk group | 8/511 (1.56) | 4/442 (0.90) | 0.362 | 6/511 (1.17) | 4/442 (0.90) | 0.684 | 2/511 (0.39) | 0/442 (0.00) | 0.188 |
Data are presented as n (%).
RLN recurrent laryngeal nerve; IONM, intraoperative neuromonitoring; VA, visualization alone; LN, lymph node.
Effects of CLND on risk of RLN injury.
| Variable | CLND (n = 597) | No CLND (n = 1099) | |
|---|---|---|---|
| Overall RLN palsy | 19 (3.18) | 15 (1.36) | 0.011 |
| Transient RLN palsy | 19 (3.18) | 12 (1.09) | 0.002 |
| Permanent RLN palsy | 0 (0.00) | 3 (0.27) | 0.201 |
CLND, central lymph node dissection; RLN, recurrent laryngeal nerve.
Spearman correlation analysis of lymph node metastasis and recurrent laryngeal nerve injury.
| Variable | Correlation coefficient (ρ) | |
|---|---|---|
| Overall lymph node metastasis | 0.361 | <0.001 |
| Central lymph node metastasis | 0.240 | 0.001 |
| Lateral lymph node metastasis | 0.439 | <0.001 |
Figure 1.Receiver operating characteristic curve for predicting recurrent laryngeal nerve injury by ratio of central lymph node metastasis. AUC, area under the curve.
EMG signal changes in 2016 and 2017.
| EMG signal (2016) | EMG signal (2017) | |||
|---|---|---|---|---|
| >50% from baseline (n = 5) | <100 µV (n = 13) | >50% from baseline (n = 10) | <100 µV (n = 7) | |
| VCP | 4 (80.00) | 9 (69.23) | 4 (40.00) | 6 (85.71) |
| No VCP | 1 (20.00) | 4 (30.77) | 6 (60.00) | 1 (14.29) |
Data are presented as n (%).
EMG, electromyographic; VCP, vocal cord paralysis.